Basic Information
ID: ALA690385
Type: Functional
Description: Compound was evaluated for its ability to inhibit a virus containing the clinically relevant K103N mutation
Organism: Human immunodeficiency virus 1
Activity Charts
Bioactivity
Activity Types for Assay ALA690385
IC90
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 317.69 | 3.48 | 3.48 |
| 316.71 | 4.20 | 4.20 |
| 314.69 | 3.65 | 3.65 |
| 355.70 | 3.71 | 3.71 |
| 345.75 | 4.42 | 4.42 |
| 331.72 | 4.03 | 4.03 |
| 411.73 | 4.80 | 4.80 |
| 371.79 | 4.65 | 4.65 |
| 357.76 | 4.26 | 4.26 |
| 359.78 | 4.81 | 4.81 |
| 329.29 | 3.91 | 3.91 |
| 371.79 | 4.50 | 4.50 |
| 345.27 | 3.49 | 3.49 |
| 331.72 | 3.73 | 3.73 |
| 329.70 | 3.48 | 3.48 |
| 347.28 | 4.05 | 4.05 |
| 365.74 | 4.12 | 4.12 |
| 343.32 | 4.30 | 4.30 |
| 315.68 | 4.07 | 4.07 |
| 343.73 | 3.87 | 3.87 |
| 327.28 | 3.35 | 3.35 |
| 341.30 | 3.74 | 3.74 |
| 343.73 | 3.87 | 3.87 |
| 327.28 | 3.35 | 3.35 |
| 341.30 | 3.74 | 3.74 |